The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Emerging transcriptional landscape and putative therapeutic targets in young patients with metastatic colorectal cancer (CRC).
 
Christopher Hanyoung Lieu
No Relationships to Disclose
 
Todd M. Pitts
No Relationships to Disclose
 
Jihye Kim
No Relationships to Disclose
 
Aik-Choon Tan
No Relationships to Disclose
 
Wells A. Messersmith
Consulting or Advisory Role - Morphotek; OncoMed
Research Funding - GlaxoSmithKline; Immunomedics; Millennium; OncoMed; Pfizer; Roche; Roche/Genentech
 
Y. Nancy You
No Relationships to Disclose
 
Cathy Eng
Honoraria - Lilly; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche
 
S. Gail Eckhardt
Stock and Other Ownership Interests - Entremed
Honoraria - Boehringer Ingelheim; Janssen Oncology; Kyowa Hakko Kirin; Lilly/ImClone
Consulting or Advisory Role - CASI Pharmaceuticals; OnKure; Pfizer; Sanofi; Suvica; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); cleave biosciences (Inst); Genentech (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech; Kyowa Hakko Kirin; Lilly/ImClone; Sanofi